Search Ontology:
ChEBI
apramycin
- Term ID
- CHEBI:2790
- Synonyms
-
- (2R,3S,4R,4aR,6S,7R,8aS)-7-amino-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy}-4-hydroxy-3-(methylamino)octahydropyrano[3,2-b]pyran-2-yl 4-amino-4-deoxy-alpha-D-glucopyranoside
- 4-O-((8R)-2-amino-8-O-(4-amino-4-deoxy-alpha-D-glucopyranosyl)-2,3,7-trideoxy-7-(methylamino)-D-glycero-alpha-D-allo-octodialdo-1,5:8,4-dipyranos-1-yl)-2-deoxy-D-streptamine
- 4-O-(3alpha-amino-6alpha-((4-amino-4-deoxy-alpha-D-glucopyranosyl)oxy)-2,3,4,5abeta,6,7,8,8aalpha-octahydro-8beta-hydroxy-7beta-(methylamino)pyrano(3,2-b)pyran-2alpha-yl)-2-deoxy-D-streptamine
- apramicina
- apramycin
- apramycine
- apramycinum
- nebramycin factor 2
- nebramycin II
- Definition
- An aminoglycoside that is 2-deoxystreptamine that is substituted on the oxygen at position 4 by an (8R)-2-amino-8-O-(4-amino-4-deoxy-alpha-D-glucopyranosyl)-2,3,7-trideoxy-7-(methylamino)-D-glycero-alpha-D-allo-octodialdo-1,5:8,4-dipyranos-1-yl) group.
- References
-
- CAS:37321-09-8
- DrugBank:DB04626
- KEGG:C01555
- KEGG:D02322
- PDBeChem:AM2
- PMID:1249675
- PMID:340441
- PMID:690031
- PMID:932851
- Patent:US3691279
- Reaxys:4610404
- VSDB:1743
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
- is a type of
-
- has_role
-
Phenotype
Phenotype resulting from apramycin
Phenotype where environments contain apramycin
Phenotype modified by environments containing apramycin
Human Disease Model